However, autologous NK cell infusion is inefficient in several cancers such as GBM [50], and autologous NK cells are likely to be inhibited by self-HLA signals in tumor cells in the absence of significant activating stimuli or CD16 interaction with antibodies. The gene discussed is FCGR3A; the disease is neoplasm.